Brokerages Set Aspen Aerogels, Inc. (NYSE:ASPN) Price Target at $12.67

Aspen Aerogels, Inc. (NYSE:ASPN) has been assigned a consensus rating of “Hold” from the ten analysts that are currently covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a sell rating, two have assigned a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $12.6667.

Several analysts have weighed in on ASPN shares. Canaccord Genuity Group cut their target price on Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating on the stock in a research note on Friday, November 7th. Zacks Research cut shares of Aspen Aerogels from a “hold” rating to a “strong sell” rating in a research note on Monday, November 10th. Barclays decreased their target price on shares of Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating for the company in a research report on Friday, November 7th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Aspen Aerogels in a research report on Tuesday.

Insiders Place Their Bets

In other Aspen Aerogels news, CEO Donald R. Young sold 56,845 shares of the company’s stock in a transaction that occurred on Thursday, November 13th. The stock was sold at an average price of $3.23, for a total value of $183,609.35. Following the completion of the sale, the chief executive officer directly owned 494,011 shares in the company, valued at $1,595,655.53. This represents a 10.32% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 4.30% of the stock is owned by company insiders.

Institutional Trading of Aspen Aerogels

Several institutional investors have recently modified their holdings of ASPN. Gagnon Securities LLC bought a new position in Aspen Aerogels during the second quarter valued at about $11,243,000. Federated Hermes Inc. bought a new position in shares of Aspen Aerogels during the 2nd quarter valued at about $10,459,000. AWM Investment Company Inc. grew its stake in shares of Aspen Aerogels by 102.6% in the 1st quarter. AWM Investment Company Inc. now owns 2,449,221 shares of the construction company’s stock worth $15,651,000 after purchasing an additional 1,240,535 shares during the last quarter. Invesco Ltd. grew its stake in shares of Aspen Aerogels by 1,045.5% in the 2nd quarter. Invesco Ltd. now owns 831,991 shares of the construction company’s stock worth $4,925,000 after purchasing an additional 759,360 shares during the last quarter. Finally, MetLife Investment Management LLC raised its holdings in shares of Aspen Aerogels by 2,036.3% in the 1st quarter. MetLife Investment Management LLC now owns 764,423 shares of the construction company’s stock worth $4,885,000 after purchasing an additional 728,641 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Trading Up 6.5%

Shares of NYSE:ASPN opened at $3.12 on Friday. The company has a quick ratio of 3.31, a current ratio of 3.98 and a debt-to-equity ratio of 0.34. The company’s 50-day moving average price is $6.62 and its 200 day moving average price is $6.61. The company has a market cap of $257.86 million, a PE ratio of -0.82 and a beta of 2.85. Aspen Aerogels has a fifty-two week low of $2.92 and a fifty-two week high of $15.38.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings results on Thursday, November 6th. The construction company reported ($0.06) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.05). The firm had revenue of $73.02 million during the quarter, compared to analyst estimates of $73.42 million. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. Aspen Aerogels’s revenue for the quarter was down 37.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.17) EPS. Aspen Aerogels has set its FY 2025 guidance at -4.150–4.050 EPS. Sell-side analysts anticipate that Aspen Aerogels will post 0.17 earnings per share for the current year.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.